Statements (15)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
nucleotide analogue |
| gptkbp:CASNumber |
1623591-94-7
|
| gptkbp:chemicalClass |
phosphoramidate prodrug
|
| gptkbp:clinicalTrialPhase |
Phase II
|
| gptkbp:developedBy |
gptkb:NuCana
|
| https://www.w3.org/2000/01/rdf-schema#label |
NUC-3373
|
| gptkbp:intendedUse |
gptkb:cancer
|
| gptkbp:mechanismOfAction |
thymidylate synthase inhibitor
|
| gptkbp:relatedTo |
gptkb:5-fluorouracil
|
| gptkbp:routeOfAdministration |
intravenous
|
| gptkbp:target |
colorectal cancer
solid tumors |
| gptkbp:bfsParent |
gptkb:NuCana
|
| gptkbp:bfsLayer |
7
|